Financed by the EU4Health programme, HERA Invest is a €100 million top-up to the InvestEU programme to support research and development (R&D) in the most pressing cross-border health threats.
This initiative gives innovative European companies access to sufficient public and private funding for the development and scaling up of cutting-edge solutions in health and life sciences. Innovation is needed to respond to priority health threats such as pathogens with high pandemic potential or resistance to antibiotics.
OBJECTIVES OF HERA INVEST
- promote R&D in Europe to strengthen strategic autonomy;
- reduce market failures, where financial resources do not cover the financing needs;
- leverage public funding to incentivise private investment;
- create new medical countermeasures to protect against health threats.
Have a look at the following two-pager factsheet on this initiative. Do not hesitate to get in touch with Emilie Fonck for more info.
More info here
